Crossmark

Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

Published Online: 2022-10-04

Published Print: 2022-11

Authors

Garofalo, Michela

Romano, Giulia

Di Leva, Gianpiero

Nuovo, Gerard

Jeon, Young-Jun

Ngankeu, Apollinaire

Sun, Jin

Lovat, Francesca

Alder, Hansjuerg

Condorelli, Gerolama

Engelman, Jeffrey A.

Ono, Mayumi

Rho, Jin Kyung

Cascione, Luciano

Volinia, Stefano

Nephew, Kenneth P.

Croce, Carlo M.
License Information

Text and Data Mining valid from 2022-10-04

Version of Record valid from 2022-10-04
More Information

Article History

First Online: 4 October 2022

Change Date: 12 October 2022

Change Type: Update

Change Details: In the version of this notice initially published, Gerald Nuovo was mistakenly listed as an author who did not respond to the journal regarding the retraction; rather, they do not agree with the retraction, as has been amended in the HTML and PDF version of this notice.

Free to read: This content has been made available to all.

Document is current